Positive survival data from a randomized Phase II trial with PM1183 in platinum resistant ovarian cancer will be presented at ASCO

by Pharmamar Zeltia

​New clinical trial data from both Yondelis® and PM1183 have been selected by The American Society of Clinical Oncology (ASCO) for oral presentations

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New advances in cancer viral immunothera...

by Universitat de Barcelona

It has been developed a new strain of vaccinia virus, which can replic...

Photos Stream